Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spero Therapeutics
Biotech
Spero speared by antibiotic flop, triggering 39% workforce cut
An interim analysis revealed a double blow to the oral antibiotic candidate, which both failed to beat placebo and showed signs of liver toxicity.
Nick Paul Taylor
Oct 30, 2024 6:30am
Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders
Aug 9, 2024 8:30am
Fierce 15: Where are they now?
Jul 26, 2024 6:50am
Gene editor Metagenomi adds C-suite execs—Chutes & Ladders
Nov 10, 2023 9:30am
GSK pays $66M to rescue Spero's antibiotic after FDA rejection
Sep 22, 2022 6:00am
Spero lays off 75% of staff, drops UTI drug after FDA meeting
May 3, 2022 10:35am
